Back to SYRE
VICTORY CAPITAL MANAGEMENT INC → SYRE
VICTORY CAPITAL MANAGEMENT INC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$48.8M
Q3 2026
Peak value
$49.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.5M |
| Q4 2025 | $4.8M |
| Q1 2026 | $14.7M |
| Q2 2026 | $49.2M |
| Q3 2026 | $48.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $48.8M | 548.7K | — | — |
| Q2 2026 | $49.2M | 554.0K | — | — |
| Q1 2026 | $14.7M | 292.1K | — | — |
| Q4 2025 | $4.8M | 146.1K | — | — |
| Q3 2025 | $5.5M | 326.1K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$348.1M
$336.7M
$318.8M